Correlation Between Microsoft and Medivie Therapeutic
Can any of the company-specific risk be diversified away by investing in both Microsoft and Medivie Therapeutic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft and Medivie Therapeutic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Microsoft and Medivie Therapeutic, you can compare the effects of market volatilities on Microsoft and Medivie Therapeutic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft with a short position of Medivie Therapeutic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft and Medivie Therapeutic.
Diversification Opportunities for Microsoft and Medivie Therapeutic
0.06 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Microsoft and Medivie is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft and Medivie Therapeutic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medivie Therapeutic and Microsoft is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft are associated (or correlated) with Medivie Therapeutic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medivie Therapeutic has no effect on the direction of Microsoft i.e., Microsoft and Medivie Therapeutic go up and down completely randomly.
Pair Corralation between Microsoft and Medivie Therapeutic
Given the investment horizon of 90 days Microsoft is expected to generate 0.25 times more return on investment than Medivie Therapeutic. However, Microsoft is 4.03 times less risky than Medivie Therapeutic. It trades about 0.09 of its potential returns per unit of risk. Medivie Therapeutic is currently generating about -0.02 per unit of risk. If you would invest 23,466 in Microsoft on September 3, 2024 and sell it today you would earn a total of 18,880 from holding Microsoft or generate 80.46% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 77.47% |
Values | Daily Returns |
Microsoft vs. Medivie Therapeutic
Performance |
Timeline |
Microsoft |
Medivie Therapeutic |
Microsoft and Medivie Therapeutic Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Microsoft and Medivie Therapeutic
The main advantage of trading using opposite Microsoft and Medivie Therapeutic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft position performs unexpectedly, Medivie Therapeutic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medivie Therapeutic will offset losses from the drop in Medivie Therapeutic's long position.Microsoft vs. Palo Alto Networks | Microsoft vs. Uipath Inc | Microsoft vs. Block Inc | Microsoft vs. Adobe Systems Incorporated |
Medivie Therapeutic vs. Batm Advanced Communications | Medivie Therapeutic vs. Brainsway | Medivie Therapeutic vs. Mivne Real Estate | Medivie Therapeutic vs. Photomyne |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Bonds Directory Find actively traded corporate debentures issued by US companies |